Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Neurochirurgie ; 64(6): 439-441, 2018 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-30274919

RESUMEN

Erdheim-Chester disease is a rare form of non-Langerhans cell histiocytosis. It is an inflammatory disorder associated with BRAF V600E mutation in 50% of cases. This multisystem disease is rarely associated with spinal involvement. Neurological involvement is an independent predictive factor of poor prognosis. The diagnosis is histopathological based on CD68-positive and CD1A-negative histiocytes. Treatment with interferon-alpha is an independent predictor of survival in Erdheim-Chester disease and vemurafenib has also been shown to be effective for BRAF V600E mutation. We report a clinical case of a 51-year-old patient with multiple and rare locations of Erdheim-Chester disease, particularly at the sphenoid sinus.


Asunto(s)
Enfermedad de Erdheim-Chester/genética , Mutación/genética , Proteínas Proto-Oncogénicas B-raf/genética , Compresión de la Médula Espinal/genética , Enfermedad de Erdheim-Chester/diagnóstico , Humanos , Interferón-alfa/metabolismo , Persona de Mediana Edad , Seno Esfenoidal/cirugía , Compresión de la Médula Espinal/diagnóstico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...